Aristeia Capital’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-248,822
Closed -$428K 801
2021
Q4
$428K Buy
+248,822
New +$423K 0.01% 460

Other funds holding HLGN.WS

Aristeia Capital's HLGN.WS Position: Q1 2022 in Review

Aristeia Capital sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q1 2022, closing a stake of 248,822 shares — an estimated $428K sold.

Aristeia Capital first reported a position in HLGN.WS in Q4 2021 and held it in 1 quarter. The position peaked at $428K in Q4 2021. 17 funds tracked by Wall St. Rank hold HLGN.WS as of Q1 2022.

  • Aristeia Capital reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q1 2022 after selling out during the quarter.
  • Aristeia Capital sold 248,822 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q1 2022, an estimated $428K.
  • Aristeia Capital first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2021 and held it in 1 quarter.
  • Aristeia Capital's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $428K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q1 2022.

Based on Aristeia Capital's 13F filing for Q1 2022, filed 16 May 2022.